DEREK JANTZ - 14 May 2021 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role: Chief Scientific Officer, Director
Signature: /s/ Dario Scimeca, Attorney-in-Fact for Derek Jantz
Issuer symbol: DTIL
Transactions as of: 14 May 2021
Net transactions value: -$87,841
Form type: 4
Filing time: 18 May 2021, 16:25:46 UTC
Previous filing: 14 May 2021
Next filing: 19 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DTIL	Common Stock	Options Exercise	$861	+21,514	+0.53%	$0.0400^*	4,061,952	14 May 2021	Direct
transaction	DTIL	Common Stock	Sale	$88,701	-9,673	-0.24%	$9.17	4,052,279	14 May 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DTIL	Employee Stock Option (Right to Buy)	Options Exercise	$0	-21,514	-100%	$0.000000^*	0	14 May 2021	Common Stock	21,514	$0.0400	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.
F2	The option is fully vested and exercisable.